JG
DMK

Jefferies Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Jefferies Group’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-230
Closed -$34K – 2947
2019
Q1 		$34K Buy
+230
New +$44.5K ﹤0.01% 2230

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jefferies Group's DMK Position: Q2 2019 in Review

Jefferies Group sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2019, closing a stake of 230 shares — an estimated $34K sold.

Jefferies Group first reported a position in DMK in Q1 2019 and held it in 1 quarter. The position peaked at $34K in Q1 2019. 51 funds tracked by Wall St. Rank hold DMK as of Q2 2019.

  • Jefferies Group reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2019 after selling out during the quarter.
  • Jefferies Group sold 230 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2019, an estimated $34K.
  • Jefferies Group first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2019 and held it in 1 quarter.
  • Jefferies Group's DMK Pharmaceuticals Corporation Common Stock position peaked at $34K in Q1 2019.
  • 51 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2019.

Based on Jefferies Group's 13F filing for Q2 2019, filed 14 Aug 2019.